Pfizer is urging the Albanese Government to use the 2026–27 Budget to reverse what it describes as chronic underinvestment in the PBS, warning that Australia is falling behind comparable countries on access to innovative medicines and vaccines and squandering large productivity gains in the process.
Pfizer calls for Budget shift, citing missed medicines and the impact of lost productivity
February 1, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Patients and clinicians defend MS treatment choice during review stakeholder meeting
November 5, 2026 - - Latest News -
Vaccines dominate public health spending but prevention investment slips
November 5, 2026 - - Latest News -
Increased accountability can be the only response to expanding authority
November 5, 2026 - - Latest News -
Sydney summit program focused on the reshaping power of AI
November 4, 2026 - - Latest News -
Is the reluctance to revisit term limits because they are such an obvious change?
November 4, 2026 - - Latest News -
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News
